Evidence map›Paper›PMID 33883783›Full record

ArticleTetrahedron2020

A decade review of triphosgene and its applications in organic reactions.

Moshood O Ganiu, Binod Nepal, Joshua P Van Houten, Rendy Kartika

Open access · greenAbstract read
In one paragraph

Article in Tetrahedron, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Access toACS organic & inorganic Au · 2025
    Article
  5. Article
  6. Article
  7. BChemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  8. Article
  9. Development of aOrganic letters · 2023
    Article
  10. Photo-on-DemandACS omega · 2023
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Moshood O GaniuDepartment of Chemistry, 232 Choppin Hall, Louisiana State University, Baton Rouge, LA 70803 United States.
Binod NepalDepartment of Chemistry, 232 Choppin Hall, Louisiana State University, Baton Rouge, LA 70803 United States.
Joshua P Van HoutenDepartment of Chemistry, 232 Choppin Hall, Louisiana State University, Baton Rouge, LA 70803 United States.
Rendy KartikaDepartment of Chemistry, 232 Choppin Hall, Louisiana State University, Baton Rouge, LA 70803 United States.
Louisiana State University · US

Funding

New Synthetic Chemistries Enabled by Oxyallyl and 2-Aminoallyl CationsR01GM127649 · NIGMS · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI KARTIKA, RENDY GREGORY · 2018 to 2022
$1.4M
NIGMS NIH HHS R01 GM127649
6 · The paper itself

Abstract

This review article highlights selected advances in triphosgene-enabled organic synthetic reactions that were reported in the decade of 2010-2019. Triphosgene is a versatile reagent in organic synthesis. It serves as a convenient substitute for the toxic phosgene gas. Despite its first known preparation in the late 19th interestingly began only three decades ago. Despite the relatively short history, triphosgene has been proven to be very useful in facilitating the preparation of a vast scope of value-added compounds, such as organohalides, acid chlorides, isocyanates, carbonyl addition adducts, heterocycles, among others. Furthermore, applications of triphosgene in complex molecules synthesis, polymer synthesis, and other techniques, such as flow chemistry and solid phase synthesis, have also emerged in the literature.

Indexed as

Bis(trichloromethyl) carbonateCarbonyl compoundsHeterocyclesOrganohalidesTriphosgene

Identifiers

PMID33883783
PMCPMC8054975
OpenAlexW3083732063

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.